Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) are highly reactive chemical species, including superoxide, hydrogen peroxide, and hydroxyl radicals, that are formed as natural byproducts of oxygen metabolism (Sies et al., 2017, Nature Reviews Molecular Cell Biology). Under physiological conditions, they serve as critical signaling molecules for cell growth, differentiation, and the immune response; however, an imbalance between ROS production and the body's antioxidant defenses leads to oxidative stress (Ray et al., 2012, Cell Signaling). The 'oxidized antioxidant pool' refers to the depletion of endogenous reducing agents, such as the conversion of reduced glutathione (GSH) to its oxidized form (GSSG), which occurs when ROS levels overwhelm cellular capacity (Frijhoff et al., 2015, Antioxidants & Redox Signaling). This state of oxidative stress causes cumulative damage to DNA, proteins, and lipids, contributing to the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases (PubMed, PMID: 22226774). Therapeutic strategies involve using antioxidants or scavengers like N-acetylcysteine or edaravone to neutralize these species or replenish the antioxidant pools (DrugBank; FDA). Despite their therapeutic potential, targeting ROS is challenging because non-selective scavenging can disrupt vital redox-sensitive signaling pathways, often leading to limited efficacy in clinical trials (NIH, National Center for Complementary and Integrative Health).
Direct chemical scavenging of free radicals, neutralization of reactive oxygen intermediates, and restoration of the reduced state of endogenous antioxidant pools such as the glutathione and thioredoxin systems.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and oxidized antioxidant pools (ROS).